Results 151 to 160 of about 19,665 (228)

Rapidly progressive fibrinopurulent pleural empyema with systemic juvenile idiopathic arthritis during treatment with tocilizumab. [PDF]

Rheumatol Adv Pract
Nawata T, Gono T, Ota Y, Suzuki M, Sakuraba M, Okazaki Y, Shirai Y, Takeno M, Kuwana M.   +8 more
europepmc   +1 more source

Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient [PDF]

Turk Arch Pediatr
Petrova AN, Kozlova OP, Verezgov VA, Gaidar EV, Zakharova ML, Ivanov DO, Kostik MM.   +6 more
europepmc   +1 more source

Pan American League of Associations for Rheumatology treatment recommendations for systemic juvenile idiopathic arthritis. [PDF]

Rheumatol Adv Pract
Franco L, Rodrigues Fonseca A, Barzola ML, Cuttica RJ, Gutierrez-Suárez R, Espada G, Silva CA, Appenzeller S, Cameto Caffa JA, Morel Z, Eraso R, Ferrándiz MA, Guarnizo Zuccardi P, Ibáñez Estrella A, Tineo Rodríguez C, Jiménez Cruz KV, Jurado RM, León BH, Herrera CN, Arroyo Rivera IL, Faugier Fuentes E, Ringer A, Ramírez Stieben LA, Brun LR, Marín Zúcaro NM, Fernández-Ávila DG, Brance ML, Talesnik E, Pan American League of Associations for Rheumatology (PANLAR) .   +28 more
europepmc   +1 more source

Drug-induced liver injury secondary to anakinra in a patient with systemic juvenile idiopathic arthritis-Case report and literature overview. [PDF]

Can Liver J
Mannala S, Kehar M, Samson L, Poulin A, Kerr T, Jariwala MP.   +5 more
europepmc   +1 more source

Risk factors for macrophage activation syndrome in systemic juvenile idiopathic arthritis: a systematic review and meta-analysis. [PDF]

Front Pediatr
Li S, Wu X, Jing S, Yang X, Zhang Y, Dong L.   +5 more
europepmc   +1 more source

Systemic juvenile idiopathic arthritis, with tinea capitis and peripheral eosinophilia: a case report. [PDF]

Ann Med Surg (Lond)
Alameen ABM, Elamin ABM, Imamaldin MGA, Elhassan M.   +3 more
europepmc   +1 more source

Breastfeeding duration and the risk of systemic juvenile idiopathic arthritis: a cross-sectional study. [PDF]

Front Nutr
Luo Q, Zhang H, Wu X, Wei X, Tang X.
europepmc   +1 more source

Exploration of common genomic signatures of systemic juvenile idiopathic arthritis and Kawasaki disease. [PDF]

Clin Rheumatol
Zhong S, Li Y, Wu L, Di Y.
europepmc   +1 more source

Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare. [PDF]

Pharmaceuticals (Basel)
Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kriulin IA, Kudlay DA, Fetisova AN, Botova MS, Kriulina TY, Krekhova EA, Kondratyeva NM, Shingarova MS, Kokina MY, Shilova AN, Kostik MM.   +13 more
europepmc   +1 more source

Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21. [PDF]

Turk Arch Pediatr
Akay N, Aslan E, Gul U, Kilic Konte E, Yildiz M, Sahin S.   +5 more
europepmc   +1 more source